Drugs / USPIO labeled MSC injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03651791 | May 2013 → Jun 2014 | ischemic disease | Rigshospitalet, Denmark | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | USPIO labeled MSC injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03651791 ↗ |
| Action | Restore | “to form new heart muscle cells and blood vessels in the myocardium” NCT03651791 ↗ |
| Modality | Cell therapy | “regenerative stem cell therapy for ischemic heart disease” PMID 31814830 ↗ Nov 2019 |
| Route | Other | “NOGA-guided intramyocardial transplantation” PMID 31814830 ↗ Nov 2019 |